What is the best medication for treating hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Best Medications for Hypertension Management

The best medications for treating hypertension are thiazide diuretics, angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), and calcium channel blockers (CCBs), which should be selected based on patient characteristics and comorbidities. 1

First-Line Medication Options

Recommended First-Line Agents

The World Health Organization (WHO) and major cardiology societies recommend the following as first-line medications for hypertension:

  1. Thiazide and thiazide-like diuretics (e.g., chlorthalidone, hydrochlorothiazide, indapamide)
  2. ACE inhibitors (e.g., lisinopril, enalapril)
  3. ARBs (e.g., candesartan, valsartan)
  4. Long-acting dihydropyridine calcium channel blockers (e.g., amlodipine) 1

Medication Selection Algorithm

  • For most patients without comorbidities: Any of the four first-line agents can be used
  • For Black patients: Calcium channel blocker or thiazide diuretic as initial therapy 2, 1
  • For patients with diabetes or CKD: ACE inhibitor or ARB preferred 2, 1
  • For patients with heart failure: ACE inhibitor/ARB, beta-blocker, mineralocorticoid receptor antagonist 2, 1
  • For patients with coronary artery disease: RAS blockers, beta-blockers with or without CCBs 1

Combination Therapy

Single-pill combinations are preferred to improve adherence 1. The WHO suggests combination therapy as an initial treatment, particularly for:

  • Patients with BP significantly above target (>20/10 mmHg above goal)
  • Black patients
  • Patients with high cardiovascular risk 1

Recommended Combinations:

  • ACE inhibitor or ARB + dihydropyridine CCB
  • ACE inhibitor or ARB + thiazide/thiazide-like diuretic
  • CCB + thiazide/thiazide-like diuretic 1

Avoid These Combinations:

  • ACE inhibitor + ARB (increased risk of adverse effects) 1, 2
  • ACE inhibitor or ARB + direct renin inhibitor 2

Treatment Intensification

For patients not reaching target BP on dual therapy:

  1. Triple therapy: ACE inhibitor/ARB + CCB + thiazide/thiazide-like diuretic
  2. If still uncontrolled, add spironolactone (25-50 mg/day)
  3. If spironolactone is not tolerated, consider eplerenone, beta-blocker, alpha-blocker, or centrally acting agent 1, 2

Blood Pressure Targets

  • Initial target for all patients: <140/90 mmHg 1
  • Optimal target for most patients: 120-129/<80 mmHg (if tolerated) 1
  • For older adults (≥65 years): 130-139 mmHg systolic 1
  • For very elderly (≥85 years) or those with orthostatic hypotension: Consider more lenient targets (<140/90 mmHg) 1

Medication-Specific Considerations

Thiazide Diuretics

  • Low-dose thiazides have shown reduction in mortality, stroke, and coronary heart disease 3
  • Chlorthalidone may be preferred over hydrochlorothiazide due to longer duration of action and stronger evidence in landmark trials 1

ACE Inhibitors

  • Reduce mortality, stroke, coronary heart disease, and cardiovascular events 3
  • Lisinopril has been shown to effectively reduce blood pressure with once-daily dosing 4
  • May cause dry cough in some patients

Calcium Channel Blockers

  • Effective at reducing stroke and cardiovascular events 3
  • Well-tolerated in most patient populations
  • Particularly effective in Black patients 1

Common Pitfalls and Caveats

  1. Inadequate dosing: Ensure medications are titrated to effective doses before adding additional agents
  2. Ignoring adherence issues: Single-pill combinations improve adherence 1
  3. Overlooking secondary causes: Consider screening for secondary hypertension in resistant cases
  4. Not accounting for white coat hypertension: Home BP monitoring is recommended for medication titration 2
  5. Drug interactions: Be aware of potential interactions, particularly with CCBs and certain antiretroviral therapies 1

Monitoring Recommendations

  • Follow up within 1 month for BP 130-139/80-89 mmHg
  • Follow up within 2-4 weeks for BP 140-159/90-99 mmHg
  • Follow up within 1-2 weeks for BP ≥160/100 mmHg 2
  • Monitor serum creatinine, eGFR, and potassium within 2-4 weeks of starting ACE inhibitors, ARBs, or diuretics 2

Remember that blood pressure control is the primary goal, regardless of which medication is used, as it is the reduction in blood pressure that provides cardiovascular benefit rather than specific properties of individual drugs 5, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hypertension Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

First-line drugs for hypertension.

The Cochrane database of systematic reviews, 2009

Research

The clinical pharmacology of lisinopril.

Journal of cardiovascular pharmacology, 1987

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.